|
PARP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.40849999999515E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.158400E-03 |
| Normal-vs-Stage2 |
3.703000E-03 |
| Normal-vs-Stage3 |
2.238100E-04 |
| Normal-vs-Stage4 |
1.546340E-02 |
| Stage1-vs-Stage2 |
3.067800E-01 |
| Stage1-vs-Stage3 |
9.081600E-02 |
| Stage1-vs-Stage4 |
4.602200E-01 |
| Stage2-vs-Stage3 |
6.585600E-01 |
| Stage2-vs-Stage4 |
9.047800E-01 |
| Stage3-vs-Stage4 |
5.952400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63748999999491E-05 |
| Normal-vs-AfricanAmerican |
2.063200E-01 |
| Normal-vs-Asian |
5.785600E-01 |
| Caucasian-vs-AfricanAmerican |
2.206000E-01 |
| Caucasian-vs-Asian |
1.844010E-01 |
| AfricanAmerican-vs-Asian |
4.029200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.28600000002E-06 |
| Normal-vs-Female |
1.097780E-02 |
| Male-vs-Female |
5.750200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.89079999996156E-06 |
| Normal-vs-Age(41-60Yrs) |
2.524200E-03 |
| Normal-vs-Age(61-80Yrs) |
9.8826999999968E-05 |
| Normal-vs-Age(81-100Yrs) |
7.383700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.196000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.910000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.376000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.500000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.083000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.287000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.345830E-01 |
| Normal-vs-Grade 2 |
1.884090E-03 |
| Normal-vs-Grade 3 |
6.12500000000127E-05 |
| Normal-vs-Grade 4 |
1.498760E-03 |
| Grade 1-vs-Grade 2 |
2.242500E-02 |
| Grade 1-vs-Grade 3 |
2.523200E-03 |
| Grade 1-vs-Grade 4 |
1.723150E-03 |
| Grade 2-vs-Grade 3 |
1.427010E-01 |
| Grade 2-vs-Grade 4 |
1.192640E-01 |
| Grade 3-vs-Grade 4 |
5.006400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.455800E-02 |
| Normal-vs-ccB subtype |
1.65149999997727E-06 |
| ccA subtype-vs-ccB subtype |
1.762270E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.539000E-03 |
| Normal-vs-N1 |
2.28790000278423E-08 |
| N0-vs-N1 |
3.576500E-04 |
|
|
